Health Wildcatters’ Pulse: Encore Vision’s ‘Out-of-Sight’ $465 Million Exit

The Pulse Healthcare Innovation Breakfast Series connects entrepreneurs, medical professionals, and innovators from the DFW healthcare and business communities. It puts you at the forefront of healthcare innovation with networking and insight into the latest healthcare startups, and you can be on your way to the office by 9 a.m.

Speakers:

Les Kreis (Courtesy of: Health Wildcatters)
Les Kreis (Courtesy of: Health Wildcatters)

Les W. Kreis Jr., Co-Managing Partner, BIOS Partners
Kreis has more than 24 years of investment experience across many types of financial instruments in both global public and private equity markets. Currently, he is a founder and co-managing partner of Bios Partners, a venture capital firm focused on early-stage biotech investments. Over the past 10 years, Kreis started several early-stage companies, occasionally served as the chief operator, served on many boards of directors, and invested in over 50 ventures in both active and passive investment capacities. Currently, Kreis serves on the board of five active portfolio companies. Previously, Kreis served as VP at HBK Investments, a multi-strategy global hedge fund based in Dallas. During his 11-year tenure with the firm, he managed a $3 billion global capital structure arbitrage portfolio comprised of stocks, bonds, and derivatives products.

Bill Burns, CEO and founder, Encore Vision

rszbillburnsv2
Bill Burns (Courtesy of: Health Wildcatters)

Mr. Burns is former president, CEO and board member of Encore Vision Inc. (2006 – Jan. 2017). Burns led the sale of Encore Vision to Novartis for $375 million in upfront payments, plus undisclosed future milestone payments. For the next few months, Burns is leading the integration of Encore Vision technology into the Novartis organization. His prior experience includes working at Alcon for 20 years. At Alcon Laboratories, Burns held a number of executive positions, most recently VP worldwide marketing for pharmaceutical and consumer products, responsible for strategic marketing direction, and input to clinical product development. Burns also worked at Bristol Myers Squibb as director of business development and for 10 years at Norwich-Eaton Laboratories He has a bachelor’s degree in biology and biochemistry and is a graduate of the Harvard Business School’s Program for Management Development.

Coffee and continental breakfast will be provided. You can register here.

Networking starts at 7:30 a.m and follows with program at 8 a.m.